Back
Koninklijke Philips NV Vs. ProQR Therapeutics NV Industry Stock Comparison
Buy
77
RYLPF
Koninklijke Philips NV
Last Price:
26.24
Seasonality Move:
-0.44%
Buy
55
PRQR
ProQR Therapeutics NV
Last Price:
1.97
Seasonality Move:
2.56%
Buy
77
Koninklijke Philips NV (RYLPF)
is a Buy
Is Koninklijke Philips NV a Buy, Sell or Hold?
- The current Koninklijke Philips NV [RYLPF] share price is $26.24. The Score for RYLPF is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- RYLPF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
ProQR Therapeutics NV (PRQR)
is a Buy
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $1.98. The Score for PRQR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- PRQR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RYLPF Stock Price Chart
What is Koninklijke Philips NV's stock price today?
-
The Koninklijke Philips NV share price today is $26.24
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYLPF is experiencing slight buying pressure.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $1.98
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing selling pressure, which indicates risk of future bearish movement.
RYLPF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.61 | Buy |
| Relative Strength Index (14 RSI): | 73.96 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.91 - 25.91) | Buy |
| Bollinger Bands (100): | (19.74 - 23.78) | Buy |
PRQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 44.32 | Sell |
| Chaikin Money Flow: | -103780 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.92 - 2.16) | Sell |
| Bollinger Bands (100): | (1.92 - 2.28) | Sell |
RYLPF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.49 | Sell |
| 20-day SMA: | 23.51 | Buy |
| 50-day SMA: | 21.71 | Buy |
| 200-day SMA: | 21.08 | Buy |
| 8-day EMA: | 25.93 | Buy |
| 20-day EMA: | 24.28 | Buy |
| 50-day EMA: | 22.55 | Buy |
| 200-day EMA: | 21.16 | Buy |
PRQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2 | Sell |
| 20-day SMA: | 1.98 | Sell |
| 50-day SMA: | 2.13 | Sell |
| 200-day SMA: | 1.8 | Buy |
| 8-day EMA: | 1.99 | Sell |
| 20-day EMA: | 2.02 | Sell |
| 50-day EMA: | 2.07 | Sell |
| 200-day EMA: | 1.96 | Buy |
Koninklijke Philips NV Earnings Growth & RYLPF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.25 per share.
Koninklijke Philips NV Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProQR Therapeutics NV Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||